This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alexander R. Irvine, MD

Arch Ophthalmol. 1995;113(1):25-26.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ARTICLE on treatment of cytomegalovirus (CMV) retinitis with an intraocular sustained-release ganciclovir implant by Martin et al¹ in the December 1994 issue of the ARCHIVES represents an important breakthrough. Past studies indicate that CMV retinitis occurs in 20% to 25% of all persons with the acquired immunodeficiency syndrome (AIDS); Douglass Jabs, MD, chair of the National Eye Institute Study of Ocular Complications of AIDS, estimated at a recent meeting of the American Academy of Ophthalmology that that figure is now approaching 50%, as medical advances are allowing patients to live longer with severely depressed CD4 cell counts. Dr Jabs stated that CMV retinitis is now the most common intraocular infection seen in large urban centers. This is thus a major problem, and the costs of present medical therapy with an indwelling venous catheter are huge, estimated at approximately $70 000 per year per patient. Statistics do not tell . . . [Full Text PDF of this Article]

Author Affiliations
San Francisco, Calif

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?